ADVATIS®, Advanced Therapies Innovative Solution, is a joint venture between SIAD Healthcare and Heamopharm Healthcare.
The companies, both with solid know-how of healthcare field, developed the SAFE2 line that offer to the customers innovative and customizable solutions in the field of cell therapy.
The ADVATIS® portfolio covers all the various stages of the processing and manipulation of stem cells and tissues. All our products are the result of continuous in depth research, made in collaboration with the end user, with the common goal to match handiness and safety.
To lear more about this JV visit our web site www.advatis.com